TickerFacts.

Femasys Inc (FEMY): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$18.69M
Year ended 2025-12-31
-$17.65M
Trailing 12 months to 2026-06-30
2020-12-31: -$4.93M2021-12-31: -$7.93M2022-12-31: -$10.73M2023-12-31: -$11.28M2024-12-31: -$19.44M2025-12-31: -$18.69M-$18.69M
2020-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$18.69Mn/m2026-03-31, From 2025-01-01
2024-12-31-$19.44Mn/m2026-03-31, From 2024-01-01
2023-12-31-$11.28Mn/m2025-03-27, From 2023-01-01
2022-12-31-$10.73Mn/m2024-03-28, From 2022-01-01
2021-12-31-$7.93Mn/m2023-07-24, From 2021-01-01
2020-12-31-$4.93Mn/a2022-03-24, From 2020-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Femasys Inc (FEMY)2025-12-31-$18.69Mn/m
QHSLab, Inc. (USAQ)2025-12-31$178.1K+25.1%
Vycor Medical Inc (VYCO)2025-12-31-$13.5Kn/m
OSR Health, Inc. (OSRH)2025-12-31-$4.33Mn/m
EBR Systems, Inc. (NONE.)2025-12-31-$53.19Mn/m
Nuo Therapeutics, Inc. (AURX)2025-12-31-$865.0Kn/m
IceCure Medical Ltd. (ICCM)2025-12-31-$14.57Mn/m
Tenon Medical, Inc. (TNON)2025-12-31-$10.74Mn/m
Intelligent Bio Solutions Inc. (INBS)2026-06-30-$11.93Mn/m

Compare FEMY, USAQ, VYCO, OSRH side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗